Skip to main content
Clinical Trials/CTRI/2021/03/031663
CTRI/2021/03/031663Not yet recruitingNot Applicable

White Blood Cell Scattergrams in COVID-19 patients – a rapid screening tool?

Pramukhswami Medical College1 site in 1 country1,000 target enrollmentStarted: August 3, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
1,000
Locations
1
Primary Endpoint
Specific pattern of sandglass pattern in COVID-19 patients

Study Overview

Brief Summary

The present study is being undertaken to evaluate the utility of the specific pattern of WBCscattergram as a screening tool for COVID-19 by establishing the sensitivityand specificity of the‘sandglass pattern’.  No study has been publishedso far from the Indian subcontinent. Hence, with the present study, we wish to study these graphic displays and whetherspecific patterns are associated with COVID-19infection.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
1.00 Year(s) to 90.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •RAT and/or RT-PCR positive COVID – 19 patients in whom haemogram was ordered.

Exclusion Criteria

  • •Suspected COVID – 19 patients, who tested negative with either RAT or RT- PCR.
  • •COVID – 19 patients in whom haemogram was not ordered.

Outcomes

Primary Outcomes

Specific pattern of sandglass pattern in COVID-19 patients

Time Frame: at baseline

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Private medical college

Study Sites (1)

Loading locations...

Similar Trials